SidaGhanaV1, PubMed, Checkpoint, bibRecord, 000571

Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting.

Identifieur interne : 000571 ( PubMed/Checkpoint ); précédent : 000570; suivant : 000572

Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting.

Auteurs : Christian Obirikorang [Ghana] ; Francis A. Yeboah

Source :

Journal of biomedical science [ 1423-0127 ] ; 2009.

RBID : pubmed:19922646

Descripteurs français

KwdFr :
- Adulte, Adulte d'âge moyen, Anémie (), Femelle, Ghana, Humains, Hémoglobines (métabolisme), Infections à VIH (), Infections à VIH (sang), Infections à VIH (traitement médicamenteux), Lymphocytes T CD4+ (cytologie), Mâle, Syndrome d'immunodéficience acquise (), Syndrome d'immunodéficience acquise (sang), Syndrome d'immunodéficience acquise (traitement médicamenteux), Thérapie antirétrovirale hautement active, Études cas-témoins, Études prospectives, Évolution de la maladie.
MESH :
- cytologie : Lymphocytes T CD4+.
- métabolisme : Hémoglobines.
- sang : Infections à VIH, Syndrome d'immunodéficience acquise.
- traitement médicamenteux : Infections à VIH, Syndrome d'immunodéficience acquise.
- Adulte, Adulte d'âge moyen, Anémie, Femelle, Ghana, Humains, Infections à VIH, Mâle, Syndrome d'immunodéficience acquise, Thérapie antirétrovirale hautement active, Études cas-témoins, Études prospectives, Évolution de la maladie.
Wicri :
- geographic : Ghana.

English descriptors

KwdEn :
- Acquired Immunodeficiency Syndrome (blood), Acquired Immunodeficiency Syndrome (complications), Acquired Immunodeficiency Syndrome (drug therapy), Adult, Anemia (complications), Antiretroviral Therapy, Highly Active, CD4-Positive T-Lymphocytes (cytology), Case-Control Studies, Disease Progression, Female, Ghana, HIV Infections (blood), HIV Infections (complications), HIV Infections (drug therapy), Hemoglobins (metabolism), Humans, Male, Middle Aged, Prospective Studies.
MESH :
- chemical , metabolism : Hemoglobins.
- geographic : Ghana.
- blood : Acquired Immunodeficiency Syndrome, HIV Infections.
- complications : Acquired Immunodeficiency Syndrome, Anemia, HIV Infections.
- cytology : CD4-Positive T-Lymphocytes.
- drug therapy : Acquired Immunodeficiency Syndrome, HIV Infections.
- Adult, Antiretroviral Therapy, Highly Active, Case-Control Studies, Disease Progression, Female, Humans, Male, Middle Aged, Prospective Studies.

Abstract

Anaemia is a frequent complication of infection with the human immunodeficiency virus (HIV) and may have multiple causes. The objective of this study was to find out if blood haemoglobin measurement could be used as an indicator for the progression of HIV/AIDS in resource-limited setting.

DOI: 10.1186/1423-0127-16-102
PubMed: 19922646

Affiliations:

Ghana

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000036
to stream PubMed, to step Curation: 000036

Links to Exploration step

pubmed:19922646

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting.</title>
<author><name sortKey="Obirikorang, Christian" sort="Obirikorang, Christian" uniqKey="Obirikorang C" first="Christian" last="Obirikorang">Christian Obirikorang</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Molecular Medicine, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana. krisobiri@yahoo.com</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Department of Molecular Medicine, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi</wicri:regionArea>
<wicri:noRegion>Kumasi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yeboah, Francis A" sort="Yeboah, Francis A" uniqKey="Yeboah F" first="Francis A" last="Yeboah">Francis A. Yeboah</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19922646</idno>
<idno type="pmid">19922646</idno>
<idno type="doi">10.1186/1423-0127-16-102</idno>
<idno type="wicri:Area/PubMed/Corpus">000036</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000036</idno>
<idno type="wicri:Area/PubMed/Curation">000036</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000036</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000036</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000036</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting.</title>
<author><name sortKey="Obirikorang, Christian" sort="Obirikorang, Christian" uniqKey="Obirikorang C" first="Christian" last="Obirikorang">Christian Obirikorang</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Molecular Medicine, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana. krisobiri@yahoo.com</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Department of Molecular Medicine, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi</wicri:regionArea>
<wicri:noRegion>Kumasi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yeboah, Francis A" sort="Yeboah, Francis A" uniqKey="Yeboah F" first="Francis A" last="Yeboah">Francis A. Yeboah</name>
</author>
</analytic>
<series><title level="j">Journal of biomedical science</title>
<idno type="eISSN">1423-0127</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acquired Immunodeficiency Syndrome (blood)</term>
<term>Acquired Immunodeficiency Syndrome (complications)</term>
<term>Acquired Immunodeficiency Syndrome (drug therapy)</term>
<term>Adult</term>
<term>Anemia (complications)</term>
<term>Antiretroviral Therapy, Highly Active</term>
<term>CD4-Positive T-Lymphocytes (cytology)</term>
<term>Case-Control Studies</term>
<term>Disease Progression</term>
<term>Female</term>
<term>Ghana</term>
<term>HIV Infections (blood)</term>
<term>HIV Infections (complications)</term>
<term>HIV Infections (drug therapy)</term>
<term>Hemoglobins (metabolism)</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Anémie ()</term>
<term>Femelle</term>
<term>Ghana</term>
<term>Humains</term>
<term>Hémoglobines (métabolisme)</term>
<term>Infections à VIH ()</term>
<term>Infections à VIH (sang)</term>
<term>Infections à VIH (traitement médicamenteux)</term>
<term>Lymphocytes T CD4+ (cytologie)</term>
<term>Mâle</term>
<term>Syndrome d'immunodéficience acquise ()</term>
<term>Syndrome d'immunodéficience acquise (sang)</term>
<term>Syndrome d'immunodéficience acquise (traitement médicamenteux)</term>
<term>Thérapie antirétrovirale hautement active</term>
<term>Études cas-témoins</term>
<term>Études prospectives</term>
<term>Évolution de la maladie</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Hemoglobins</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Ghana</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term>
<term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term>
<term>Anemia</term>
<term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr"><term>Lymphocytes T CD4+</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>CD4-Positive T-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term>
<term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Hémoglobines</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Infections à VIH</term>
<term>Syndrome d'immunodéficience acquise</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à VIH</term>
<term>Syndrome d'immunodéficience acquise</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Antiretroviral Therapy, Highly Active</term>
<term>Case-Control Studies</term>
<term>Disease Progression</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Anémie</term>
<term>Femelle</term>
<term>Ghana</term>
<term>Humains</term>
<term>Infections à VIH</term>
<term>Mâle</term>
<term>Syndrome d'immunodéficience acquise</term>
<term>Thérapie antirétrovirale hautement active</term>
<term>Études cas-témoins</term>
<term>Études prospectives</term>
<term>Évolution de la maladie</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Anaemia is a frequent complication of infection with the human immunodeficiency virus (HIV) and may have multiple causes. The objective of this study was to find out if blood haemoglobin measurement could be used as an indicator for the progression of HIV/AIDS in resource-limited setting.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19922646</PMID>
<DateCreated><Year>2009</Year>
<Month>11</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted><Year>2010</Year>
<Month>02</Month>
<Day>12</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1423-0127</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>16</Volume>
<PubDate><Year>2009</Year>
<Month>Nov</Month>
<Day>18</Day>
</PubDate>
</JournalIssue>
<Title>Journal of biomedical science</Title>
<ISOAbbreviation>J. Biomed. Sci.</ISOAbbreviation>
</Journal>
<ArticleTitle>Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting.</ArticleTitle>
<Pagination><MedlinePgn>102</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/1423-0127-16-102</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Anaemia is a frequent complication of infection with the human immunodeficiency virus (HIV) and may have multiple causes. The objective of this study was to find out if blood haemoglobin measurement could be used as an indicator for the progression of HIV/AIDS in resource-limited setting.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Two hundred and twenty-eight (228) consented People Living with HIV/AIDS (PLWHAs) who were placed in three groups according to their CD4 counts were used in the study. The three groups were those with CD4 counts (1) >or= 500 mm-(3); (2) 200-499 mm-(3); and (3) <200 mm-(3). One hundred (100) sex, age-matched and healthy HIV-seronegative individuals were used as control subjects. Blood haemoglobin, blood haematocrit, Red cell indices which included Mean Cell Volume, Mean Cell Haemoglobin Concentration and Mean Cell Haemoglobin and CD4 count were analysed in all subjects.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean blood haemoglobin concentrations in those with CD4 counts <200 mm-(3), 200-499 mm-(3) and >or= 500 mm-(3) (8.83 +/- 0.22 g/dl, 10.03 +/- 0.31 g/dl and 11.3 +/- 0.44 g/dl respectively) were significantly lower when compared with the control group (14.29 +/- 0.77 g/dl) (p < 0.0001). The mean blood haematocrit levels in those with CD4 counts <200 mm-3, 200-499 mm-3 and >or= 500 mm-(3) (23.53 +/- 0.85%, 28.28 +/- 0.77% and 33.54 +/- 1.35% respectively) were also significantly lower when compared with the control group (41.15 +/- 2.15%) (p < 0.0001). The red cell indices were also lower in the subjects when compared with the control group. Using the Pearson's correlation, there was a significant and positive correlation between the blood haemoglobin level and their CD4 counts (r(2) = 0.1755; p < 0.0001).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Anaemia in People Living with HIV/AIDS, if persistent, is associated with substantially decreased survival. From our analysis, there was a decrease in the blood haemoglobin, levels as the HIV infection progressed and our findings are consistent with those of other studies of anaemia as a prognostic factor in HIV infection. Haemoglobin levels could be measured easily where resources for more sophisticated laboratory markers such as viral load or even CD4 lymphocyte count are not available given that measurement of the CD4 lymphocyte count requires flow cytometry, an expensive technique unavailable in many developing countries. Regular measurements could help to determine which patients are at greatest risk of disease progression, allowing these patients to be identified for closer monitoring or therapeutic intervention.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Obirikorang</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Molecular Medicine, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana. krisobiri@yahoo.com</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yeboah</LastName>
<ForeName>Francis A</ForeName>
<Initials>FA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2009</Year>
<Month>11</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>J Biomed Sci</MedlineTA>
<NlmUniqueID>9421567</NlmUniqueID>
<ISSNLinking>1021-7770</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Am J Med. 2004 Apr 5;116 Suppl 7A:27S-43S</RefSource>
<PMID Version="1">15050884</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Res Ther. 2007 May 14;4:11</RefSource>
<PMID Version="1">17502001</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Sep 1;19(1):29-33</RefSource>
<PMID Version="1">9732065</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1991 May 9;324(19):1332-8</RefSource>
<PMID Version="1">2017230</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Drugs. 1990 Apr;39(4):597-638</RefSource>
<PMID Version="1">2161731</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1994 Nov 1;153(9):4303-10</RefSource>
<PMID Version="1">7523521</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 1993 Jul;168(1):101-5</RefSource>
<PMID Version="1">8515096</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 1993 Sep;7(9):1159-66</RefSource>
<PMID Version="1">8105806</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Epidemiol. 1997 Nov;50(11):1241-8</RefSource>
<PMID Version="1">9393380</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 1993 Oct;7(10):959-67</RefSource>
<PMID Version="1">7903542</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Haematol. 1991 Jul;47(1):60-4</RefSource>
<PMID Version="1">1868915</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Med Clin North Am. 1992 May;76(3):699-709</RefSource>
<PMID Version="1">1578965</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>HIV Med. 2006 Jul;7(5):323-30</RefSource>
<PMID Version="1">16945078</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Intern Med. 1990 Oct;228(4):353-60</RefSource>
<PMID Version="1">2266345</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J STD AIDS. 2004 Aug;15(8):538-42</RefSource>
<PMID Version="1">15307965</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 1990 Aug;4(8):749-57</RefSource>
<PMID Version="1">1979744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Scand J Infect Dis. 1991;23(4):443-9</RefSource>
<PMID Version="1">1683492</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 1997 Feb;11(2):209-16</RefSource>
<PMID Version="1">9030369</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 1995 Feb;9(2):145-52</RefSource>
<PMID Version="1">7718184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 1992 Mar 25;267(12):1631-6</RefSource>
<PMID Version="1">1347321</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 1992 Nov 11;268(18):2516-7</RefSource>
<PMID Version="1">1404816</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Med Clin North Am. 1997 Mar;81(2):449-70</RefSource>
<PMID Version="1">9093237</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Public Health. 1992 Nov;82(11):1538-41</RefSource>
<PMID Version="1">1359801</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 2003 Jan 3;17(1):119-21</RefSource>
<PMID Version="1">12478077</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Epidemiol. 1996 Jan;49(1):59-65</RefSource>
<PMID Version="1">8598512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J STD AIDS. 1998 Aug;9(8):463-70</RefSource>
<PMID Version="1">9702595</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gynecol Obstet Invest. 1999;47(2):76-82</RefSource>
<PMID Version="1">9949275</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1996 Jan 11;334(2):123-4</RefSource>
<PMID Version="1">8531955</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 1992 Feb;165(2):352-63</RefSource>
<PMID Version="1">1346152</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncology (Williston Park). 1996 May;10(5):671-80</RefSource>
<PMID Version="1">8738824</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 1999 May 28;13(8):943-50</RefSource>
<PMID Version="1">10371175</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 1998 Oct 22;12(15):2031-9</RefSource>
<PMID Version="1">9814872</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 15;15(5):346-55</RefSource>
<PMID Version="1">9342254</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 2005 Jun;34(3):577-84</RefSource>
<PMID Version="1">15737969</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):383-92</RefSource>
<PMID Version="1">15097155</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 1989 Jun 2;261(21):3104-7</RefSource>
<PMID Version="1">2716142</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 1994 Mar;7(3):287-95</RefSource>
<PMID Version="1">8106968</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Haematologica. 1992 May-Jun;77(3):233-6</RefSource>
<PMID Version="1">1427429</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 1992 Oct;166(4):710-6</RefSource>
<PMID Version="1">1382106</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000163" MajorTopicYN="N">Acquired Immunodeficiency Syndrome</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000740" MajorTopicYN="N">Anemia</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D023241" MajorTopicYN="N">Antiretroviral Therapy, Highly Active</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N" Type="Geographic">Ghana</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC2783029</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year>
<Month>08</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2009</Year>
<Month>11</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>11</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>11</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>2</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19922646</ArticleId>
<ArticleId IdType="pii">1423-0127-16-102</ArticleId>
<ArticleId IdType="doi">10.1186/1423-0127-16-102</ArticleId>
<ArticleId IdType="pmc">PMC2783029</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Ghana</li>
</country>
</list>
<tree><noCountry><name sortKey="Yeboah, Francis A" sort="Yeboah, Francis A" uniqKey="Yeboah F" first="Francis A" last="Yeboah">Francis A. Yeboah</name>
</noCountry>
<country name="Ghana"><noRegion><name sortKey="Obirikorang, Christian" sort="Obirikorang, Christian" uniqKey="Obirikorang C" first="Christian" last="Obirikorang">Christian Obirikorang</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000571 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000571 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:19922646
   |texte=   Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:19922646" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SidaGhanaV1

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024

	Le SIDA au Ghana (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Le SIDA au Ghana (serveur d'exploration)

Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting.

Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki